免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

ETEST吉普他汀(GEP)(0.016-256 µg/mL)

K号: K260447 · 2026-04-21

决定日期2026-04-21
产品代码JWY
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

ETEST Gepotidacin (GEP) (0.016-256 µg/mL) is the device name listed in this FDA 510(k) record. The listed applicant is bioMérieux SA. It received FDA 510(k) clearance on 2026-04-21 under 510(k) number K260447. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ETEST Gepotidacin (GEP) (0.016-256 µg/mL)?

ETEST Gepotidacin (GEP) (0.016-256 µg/mL) is a medical device that received FDA 510(k) clearance on 2026-04-21. The listed applicant is bioMérieux SA. The 510(k) number is K260447.

When did ETEST Gepotidacin (GEP) (0.016-256 µg/mL) receive FDA 510(k) clearance?

ETEST Gepotidacin (GEP) (0.016-256 µg/mL) received FDA 510(k) clearance on 2026-04-21, under 510(k) number K260447.

Who is the listed applicant for ETEST Gepotidacin (GEP) (0.016-256 µg/mL)?

The FDA 510(k) record lists bioMérieux SA as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ETEST Gepotidacin (GEP) (0.016-256 µg/mL)?

The FDA product code for ETEST Gepotidacin (GEP) (0.016-256 µg/mL) is JWY.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明bioMérieux SA为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:JWY)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑